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Vasoactive intestinal peptide and inflammatory 
cytokines enhance vascular endothelial growth 
factor production from epidermal keratinocytes
In this study, Kakurai et al. attempted to determine whether 
vasoactive intestinal peptide (VIP) could increase the pro-
duction of vascular endothelial growth factor (VEGF) in 
human keratinocytes. They demonstrated that human kerati-
nocytes produced VEGF in a steady state at both mRNA and 
protein levels. VIP significantly upregulated the production 
of VEGF in keratinocytes in a dose- and time-dependent 
manner. The VIP-mediated production of VEGF was further 
enhanced by inflammatory cytokines such as interferon-γ, 
tumour necrosis factor-a and interleukin-4, with maximum 
enhancement being observed with the combination of VIP 
and interferon-γ. This may underlie excessive angiogenesis 
and vasodilation in skin lesions of psoriasis. Br J Dermatol 
2009; 161: 1232–8.
Low bone mineral density in adult patients  
with moderate to severe atopic dermatitis
The aim was to assess the prevalence of osteoporosis and 
osteopenia in adult patients with moderate to severe atopic 
dermatitis. In addition, the associations between topical⁄oral 
corticosteroid use and bone mineral density (BMD) and 
between disease activity and BMD were studied. One hundred 
and twenty-five adult patients with moderate to severe atopic 
dermatitis were studied. Osteoporosis was documented in six 
patients (4.8%) and osteopenia in 41 patients (32.8%); 30.4% 
of the patients had a Z-score ≤ –1 (low BMD), with more men 
(43.8%) than women (16.4%) affected. There was no significant 
association between low BMD and biochemical parameters 
of bone metabolism, serum thymus and activation-regulated 
chemokine levels and cumulative dose of topical and oral 
corticosteroids during the 5 years prior to inclusion. Br J 
Dermatol 2009; 161: 1248–54.
Impact of dermoscopy and short-term 
sequential digital dermoscopy imaging  
for the management of pigmented lesions  
in primary care: a sequential intervention trial
This study aimed to assess the impact of dermoscopy and 
short-term sequential digital dermoscopy imaging (SDDI) 
on the management of suspicious pigmented skin lesions 
by primary care physicians. Following the use of SDDI on 
374 lesions, 163 lesions (43.6%) were excised or referred, 
representing a reduction of 56.4%. Of the 323 lesions 
confirmed to be benign, 118 (36.5%) were excised or 
referred, leading to a reduction of 63.5% (P < 0·0005) in 
those requiring excision or referral. The baseline naked eye 
examination benign to melanoma ratio was 9.5 : 1 which 
decreased to 3.5 : 1 after the diagnostic interventions 
(P < 0.0005). Of the 42 malignant lesions included 
(34 melanoma, six pigmented basal cell carcinoma and 
two Bowen disease) only one in situ melanoma was incor-
rectly managed (patient to return if changes occur) resulting 
in the correct management of 97.6% and 97.1% of malig-
nant pigmented lesions and melanoma, respectively. In a 
primary care setting the combination of dermoscopy and 
short-term SDDI reduced the excision or referral of benign 
pigmented lesions by more than half while nearly doubling 
the sensitivity for the diagnosis of melanoma. Br J Dermatol 
2009; 161: 1270–7.
The prevalence of chromium allergy  
in Denmark is currently increasing  
as a result of leather exposure
This study aimed to investigate the development of chromi-
um allergy among patients with dermatitis tested between 
1985 and 2007 in Denmark, and to determine causative 
exposures in patients with chromium allergy. The prevalence 
of chromium allergy decreased significantly from 3.6% in 
1985 to 1% in 1995 (Ptrend  < 0.001) but increased to 3.3% 
in 2007 (Ptrend < 0.001). The frequency of clinically relevant 
cement exposure decreased significantly among patients 
with chromium allergy, from 12.7% in 1989–1994 to 3.0% 
(P < 0.01) in 1995–2007, whereas the frequency of relevant 
leather exposure increased significantly from 24.1% dur-
ing 1989–1994 to 45.5% during 1995–2007 (P < 0.02). 
Chromium allergy is currently increasing in Denmark due to 
leather exposure. Br J Dermatol 2009; 161: 1288–93.
A randomized controlled trial  
of R-salbutamol for topical treatment  
of discoid lupus erythematosus
This study aimed to compare the efficacy and safety of 
R-salbutamol cream 0.5% vs. placebo on discoid lupus 
erythematosus (DLE) lesions in a multicentre, double-
blinded, randomized, placebo-controlled phase II trial. 
Thirty-seven patients with at least one newly developed 
DLE lesion were randomized – 19 to the R-salbutamol 
cream 0.5% and 18 to placebo – and treated twice daily for 
8 weeks. The mean area under the curve of improvement 
for scaling⁄hypertrophy, pain, itching and global patient 
assessment was significantly better for the actively treated 
patients as compared with placebo (P = 0.0262, P = 0.0238, 
P = 0.0135 and P = 0.045, respectively). Moreover, the 
percentage of patients without induration was significantly 
higher in the active group compared with the placebo 
group (P = 0.013), and a statistically significantly greater 
decrease in the size of the lesional area was also seen in 
the overall analysis of the R-salbutamol-treated patients 
(P = 0.0197). No serious adverse events were reported. 
Br J Dermatol 2009; 161: 1365–70.
